BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Puchert M, Obst J, Koch C, Zieger K, Engele J. CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7. Cytokine 2020;125:154809. [PMID: 31437604 DOI: 10.1016/j.cyto.2019.154809] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Bose S, Saha P, Chatterjee B, Srivastava AK. Chemokines driven ovarian cancer progression, metastasis and chemoresistance: potential pharmacological targets for cancer therapy. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.03.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lin D, Zhao W, Yang J, Wang H, Zhang H. Integrative Analysis of Biomarkers and Mechanisms in Adamantinomatous Craniopharyngioma. Front Genet 2022;13:830793. [DOI: 10.3389/fgene.2022.830793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhang Y, Luo X, Yu J, Qian K, Zhu H. An Immune Feature-Based, Three-Gene Scoring System for Prognostic Prediction of Head-and-Neck Squamous Cell Carcinoma. Front Oncol 2021;11:739182. [PMID: 35087741 DOI: 10.3389/fonc.2021.739182] [Reference Citation Analysis]
4 Fowler D, Nattress C, Navarrete AS, Barisa M, Fisher J. Payload Delivery: Engineering Immune Cells to Disrupt the Tumour Microenvironment. Cancers (Basel) 2021;13:6000. [PMID: 34885108 DOI: 10.3390/cancers13236000] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Cannon A, Thompson CM, Bhatia R, Kandy RRK, Solheim JC, Batra SK, Kumar S. Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies. Biochim Biophys Acta Rev Cancer 2021;1876:188628. [PMID: 34560199 DOI: 10.1016/j.bbcan.2021.188628] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Cao F, Fan Y, Yu Y, Yang G, Zhong H. Dissecting Prognosis Modules and Biomarkers in Glioblastoma Based on Weighted Gene Co-Expression Network Analysis. Cancer Manag Res 2021;13:5477-89. [PMID: 34267555 DOI: 10.2147/CMAR.S310346] [Reference Citation Analysis]
7 Liang J, Jin Z, Kuang J, Feng H, Zhao Q, Yang Z, Zhan L, Shen B, Yan J, Cai W, Cheng X, Qiu W. The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis. Br J Cancer 2021;125:390-401. [PMID: 34088989 DOI: 10.1038/s41416-021-01340-x] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
8 Liu MJ, Guo H, Jiang LL, Jiao M, Wang SH, Tian T, Fu X, Wang WJ. Elevated RBP-Jκ and CXCL11 Expression in Colon Cancer is Associated with an Unfavorable Clinical Outcome. Cancer Manag Res 2021;13:3651-61. [PMID: 33981164 DOI: 10.2147/CMAR.S298580] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Yanagiya M, Dawood RIH, Maishi N, Hida Y, Torii C, Annan DA, Kikuchi H, Yanagawa Matsuda A, Kitamura T, Ohiro Y, Shindoh M, Tanaka S, Kitagawa Y, Hida K. Correlation between endothelial CXCR7 expression and clinicopathological factors in oral squamous cell carcinoma. Pathol Int 2021;71:383-91. [PMID: 33783897 DOI: 10.1111/pin.13094] [Reference Citation Analysis]
10 Cao Y, Jiao N, Sun T, Ma Y, Zhang X, Chen H, Hong J, Zhang Y. CXCL11 Correlates With Antitumor Immunity and an Improved Prognosis in Colon Cancer. Front Cell Dev Biol 2021;9:646252. [PMID: 33777950 DOI: 10.3389/fcell.2021.646252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
11 Puchert M, Koch C, Zieger K, Engele J. Identification of CXCL11 as part of chemokine network controlling skeletal muscle development. Cell Tissue Res 2021;384:499-511. [PMID: 33502606 DOI: 10.1007/s00441-020-03398-0] [Reference Citation Analysis]
12 Huynh C, Henrich A, Strasser DS, Boof ML, Al-Ibrahim M, Meyer Zu Schwabedissen HE, Dingemanse J, Ufer M. A Multipurpose First-in-Human Study With the Novel CXCR7 Antagonist ACT-1004-1239 Using CXCL12 Plasma Concentrations as Target Engagement Biomarker. Clin Pharmacol Ther 2021;109:1648-59. [PMID: 33406277 DOI: 10.1002/cpt.2154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Grzywa TM, Klicka K, Włodarski PK. Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis. Cancers (Basel) 2020;12:E3709. [PMID: 33321819 DOI: 10.3390/cancers12123709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
14 Yan S, Fang J, Chen Y, Xie Y, Zhang S, Zhu X, Fang F. Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer. BMC Cancer 2020;20:1205. [PMID: 33287740 DOI: 10.1186/s12885-020-07695-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
15 Bi Y, Shirure VS, Liu R, Cunningham C, Ding L, Meacham JM, Goedegebuure SP, George SC, Fields RC. Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression. Integr Biol (Camb) 2020;12:221-32. [PMID: 32930334 DOI: 10.1093/intbio/zyaa017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
16 Koch C, Engele J. Functions of the CXCL12 Receptor ACKR3/CXCR7-What Has Been Perceived and What Has Been Overlooked. Mol Pharmacol 2020;98:577-85. [PMID: 32883765 DOI: 10.1124/molpharm.120.000056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
17 Huynh C, Dingemanse J, Meyer Zu Schwabedissen HE, Sidharta PN. Relevance of the CXCR4/CXCR7-CXCL12 axis and its effect in pathophysiological conditions. Pharmacol Res 2020;161:105092. [PMID: 32758634 DOI: 10.1016/j.phrs.2020.105092] [Cited by in Crossref: 6] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
18 Phan QT, Tan WH, Liu R, Sundaram S, Buettner A, Kneitz S, Cheong B, Vyas H, Mathavan S, Schartl M, Winkler C. Cxcl9l and Cxcr3.2 regulate recruitment of osteoclast progenitors to bone matrix in a medaka osteoporosis model. Proc Natl Acad Sci U S A 2020;117:19276-86. [PMID: 32719141 DOI: 10.1073/pnas.2006093117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
19 Zhang X, Wang Y, Li X, Yang A, Li Z, Wang D. The anti-carcinogenesis properties of erianin in the modulation of oxidative stress-mediated apoptosis and immune response in liver cancer. Aging (Albany NY) 2019;11:10284-300. [PMID: 31754081 DOI: 10.18632/aging.102456] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]